WEALTH EFFECTS LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 1 filers reported holding IMMUNITYBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEALTH EFFECTS LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$90,415
-54.2%
53,500
-24.6%
0.04%
-48.3%
Q2 2023$197,380
+280.5%
71,000
+149.1%
0.09%
+222.2%
Q1 2023$51,870
-64.1%
28,5000.0%0.03%
-67.1%
Q4 2022$144,495
+1.8%
28,5000.0%0.08%
-5.7%
Q3 2022$142,000
+136.7%
28,500
+78.1%
0.09%
+141.7%
Q2 2022$60,000
-3.2%
16,000
+45.5%
0.04%
+24.1%
Q1 2022$62,00011,0000.03%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders